Queen’s Marque, 600-1741 Lower Water Street, Halifax, Nova Scotia B3J 0J2; and of each of the other Reporting Persons identified above is 207 High Point Drive, Victor, New York 14564.
The principal business of: (i) CBG is private investment; (ii) GII is private investment; (iii) GIIH is private investment; (iv) Greenstar LP is private investment; (v) GCIC is to serve as the general partner of Greenstar LP; (vi) Constellation Brands Canada Holdings ULC is private investment; (vii) Constellation Capital LLC is private investment; (viii) Constellation International Holdings Limited is private investment; and (ix) Constellation is a leading international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy.
Current information concerning the identity and background of each executive officer and director of CBG, GII, GIIH, GCIC, Constellation Brands Canada Holdings ULC, Constellation Capital LLC, Constellation International Holdings Limited and Constellation is set forth on Annex A (collectively, the “Covered Persons”), attached hereto and incorporated herein by reference.
(d) – (e) None of the Reporting Persons or, to the best knowledge of CBG and Greenstar LP, any of the Covered Persons has, during the past five years, been (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors), or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which he, she or it is or was subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f) CBG, GII, and GIIH are each Delaware limited liability companies; Greenstar LP and GCIC were each formed in British Columbia; Constellation Brands Canada Holdings ULC was formed in Nova Scotia; Constellation Capital LLC is a Delaware limited liability company; Constellation International Holdings Limited is a New York corporation; and Constellation Brands, Inc. is a Delaware corporation.
Item 4. Purpose of Transaction
Item 4 of the Schedule 13D is hereby revised and supplemented with the following:
Prior to April 29, 2021, CBG, GII and GIIH were each wholly-owned direct subsidiaries of Constellation. As previously reported and also as of April 29, 2021, CBG beneficially owned (i) 104,500,000 Common Shares of the Issuer, (ii) 88,472,861 Modified Tranche A Warrants exercisable at a price of C$50.40 per Common Share and expiring, in accordance with their terms, on November 1, 2023, (iii) 38,454,444 Modified Tranche B Warrants exercisable upon the exercise, in full, of the Modified Tranche A Warrants, at an exercise price of C$76.68 per share, and (iv) 12,818,148 Tranche C Warrants exercisable upon the exercise, in full, of the Modified Tranche A Warrants, at an exercise price based on the five-day volume-weighted trading price of the Issuer’s common shares on the Toronto Stock Exchange immediately prior to exercise. The Modified Tranche B Warrants and the Tranche C Warrants will expire on November 1, 2026. Additionally, the exercise price of the Tranche B Warrants and the Tranche C Warrants may be reduced in certain circumstances.
On April 29, 2021, in connection with an internal subsidiary reorganization Constellation contributed its entire interest in CBG to GII in exchange for additional common and new preferred membership interest units in GII, and then, also on April 29, 2021, Constellation contributed all the common and preferred membership interest units it held in GII to GIIH in exchange for additional common membership interests in GIIH. As a result of these membership interest contributions, GII and GIIH became Reporting Persons, GIIH remained a wholly-owned direct subsidiary of Constellation, and CBG and GII became wholly-owned indirect subsidiaries of Constellation. CBG continues to directly beneficially own the previously reported 104,500,000 Common Shares, the Modified Tranche A Warrants, the Modified Tranche B Warrants and the Tranche C Warrants.
Except as set forth in this Amendment, the Reporting Persons have no present plans or proposals that relate to or would result in any of the actions described in Item 4(a) through (j) of Schedule 13D. The Reporting Persons may evaluate on a continuing basis their investment in the Issuer and expect that they may from time to time acquire or dispose of Common Shares or other securities of the Issuer. The Reporting Persons may purchase or sell Common Shares or exercise the warrants in the future, either on the open market or in private transactions, in each case, depending on a number of factors, including general market and economic conditions
Page 7 of 17